Norepinephrine

monoamine oxidase A ; Mus musculus







31 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35332321 Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. 2022 Apr 2
2 34004054 Activation of GCN2 in macrophages promotes white adipose tissue browning and lipolysis under leucine deprivation. 2021 Jun 2
3 28953873 Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. 2017 Oct 5 3
4 26959532 Oxidative Stress by Monoamine Oxidase-A Impairs Transcription Factor EB Activation and Autophagosome Clearance, Leading to Cardiomyocyte Necrosis and Heart Failure. 2016 Jul 1 2
5 25890242 Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity. 2015 Feb 25 1
6 23581564 Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. 2014 Jan 10 1
7 22738191 p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. 2013 Jan 1 1
8 23926250 Rines E3 ubiquitin ligase regulates MAO-A levels and emotional responses. 2013 Aug 7 2
9 22723698 NMDARs mediate the role of monoamine oxidase A in pathological aggression. 2012 Jun 20 2
10 22971542 Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. 2012 Dec 2
11 21832987 Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. 2011 Dec 1
12 21971001 Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. 2011 1
13 19910579 Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. 2010 Jan 8 2
14 18585703 On the mechanism of antidepressant-like action of berberine chloride. 2008 Jul 28 1
15 18652859 Monoamine oxidase inactivation: from pathophysiology to therapeutics. 2008 Oct-Nov 1
16 17441000 Effect of MAO A deficiency on different kinds of aggression and social investigation in mice. 2007 Jan-Feb 2
17 14697877 Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. 2004 Jan 1
18 12605405 Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus. 2003 Mar 15 2
19 11880481 Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. 2002 Mar 1 1
20 11959640 Heart rate dynamics in monoamine oxidase-A- and -B-deficient mice. 2002 May 1
21 12028362 Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice. 2002 May 1
22 11750790 Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B. 2001 Nov 15 1
23 11113335 Regional cerebral cortical activation in monoamine oxidase A-deficient mice: differential effects of chronic versus acute elevations in serotonin and norepinephrine. 2000 1
24 11229360 Ginkgo biloba abolishes aggression in mice lacking MAO A. 2000 Fall 2
25 10389141 Role of MAO A and B in neurotransmitter metabolism and behavior. 1999 Jan-Feb 1
26 11281992 Knockout Corner: Knockout mice for monoamine oxidase A. 1999 Sep 1
27 9712661 Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. 1998 Sep 1 1
28 9159177 Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. 1997 May 27 4
29 9326944 Increased stress response and beta-phenylethylamine in MAOB-deficient mice. 1997 Oct 1
30 7792602 Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. 1995 Jun 23 1
31 2786196 Comparison of intra- and extrasynaptosomal monoamine oxidase-A and -B activities in the striatum and frontal cortex of two mice strains with different sensitivities to the neurotoxic actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 1989 Mar 1